Effect of Vitamin B6 Versus Propranolol on Antipsychotic-Induced Akathisia: A pilot Comparative Double-blind Study
Author | Narges Shams-Alizadeh | en |
Author | Hamid Bakhshayesh | en |
Author | Farzin Rezaei | en |
Author | Ebrahim Ghaderi | en |
Author | Nasim Shams-Alizadeh | en |
Author | Kambiz Hassanzadeh | en |
Issued Date | 2018-03-31 | en |
Abstract | Akathisia is a common adverse effect of antipsychotic drugs and is characterized by subjective feelings of restlessness. First-line treatment usually consists of propranolol, a beta adrenergic antagonist. However, propranolol does not seem to be efficacious in up to 70% of patients. This study was aimed to evaluate the effect of vitamin B6 versus propranolol on antipsychotic-induced akathisia (AIA). This study was a comparative, double-blind, randomized trial. In the present study, 66 adult patients with antipsychotic-induced akathisia were enrolled and randomized into three groups, and received vitamin B6 300 mg/12 h or 600 mg/12 h or propranolol 20 mg/12 h. The diagnosis of AIA was made by clinical examination and its severity was assessed by the Barnes Akathisia Rating Scale. | en |
DOI | https://doi.org/10.22037/ijpr.2018.2205 | en |
Keyword | Antipsychotic | en |
Keyword | Akathisia | en |
Keyword | Clinical trial | en |
Keyword | Propranolol | en |
Keyword | Vitamin B6 | en |
Publisher | Brieflands | en |
Title | Effect of Vitamin B6 Versus Propranolol on Antipsychotic-Induced Akathisia: A pilot Comparative Double-blind Study | en |
Type | Original Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ijpr-17-130.pdf
- Size:
- 437.95 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF